Literature DB >> 2729913

Amaurosis fugax associated with antiphospholipid antibodies.

K B Digre1, F J Durcan, D W Branch, D M Jacobson, M W Varner, J R Baringer.   

Abstract

In more than 50% of amaurosis fugax patients under 45 years of age no cause for the episodes of visual loss is identifiable. We have encountered 6 young adults (4 women and 2 men) with episodes of amaurosis fugax associated with elevated levels of antiphospholipid antibodies. Splinter hemorrhages of the nail beds were present in most patients. Treatment with antiplatelet medications and anticoagulants appeared to reduce the frequency of episodes and might prevent central retinal artery occlusions or stroke.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2729913     DOI: 10.1002/ana.410250304

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  12 in total

1.  The primary antiphospholipid syndrome: case report.

Authors:  S Severi; M Ghezzi; M Felici
Journal:  Ital J Neurol Sci       Date:  1992-10

2.  Visual scotomata resulting from lupus anticoagulant in a patient with lymphoma in remission.

Authors:  M L Gruber; F H Hochberg
Journal:  J Neurooncol       Date:  1991-12       Impact factor: 4.130

3.  Subungual splinter haemorrhages: a new sign of the antiphospholipid coagulopathy?

Authors:  R A Asherson
Journal:  Ann Rheum Dis       Date:  1990-04       Impact factor: 19.103

Review 4.  Coagulation abnormalities and cerebral infarction.

Authors:  M Greaves
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-05       Impact factor: 10.154

Review 5.  Primary antiphospholipid antibody syndrome and cerebral ischemia: report on acute intervention in two cases and literature review with emphasis on therapeutic options.

Authors:  S Braune; R Siekmann; P Vaith; C H Lücking
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

6.  Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies. A mouse model.

Authors:  L Ziporen; Y Shoenfeld; Y Levy; A D Korczyn
Journal:  J Clin Invest       Date:  1997-08-01       Impact factor: 14.808

7.  Retinal, ophthalmic, or ocular migraine.

Authors:  Shilpi Pradhan; Sophia M Chung
Journal:  Curr Neurol Neurosci Rep       Date:  2004-09       Impact factor: 5.081

Review 8.  Antiphospholipid syndrome and vascular ischemic (occlusive) diseases: an overview.

Authors:  Penka A Atanassova
Journal:  Yonsei Med J       Date:  2007-12-31       Impact factor: 2.759

9.  Visual scotomata resulting from lupus anticoagulant in a patient with lymphoma in remission.

Authors:  M L Gruber; F H Hochberg
Journal:  J Neurooncol       Date:  1991-08       Impact factor: 4.130

10.  Antiphospholipid antibodies syndrome and cerebral ischemia.

Authors:  S Severi; M Ghezzi; M Felici; A Miele
Journal:  Ital J Neurol Sci       Date:  1993-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.